Mealey's (March 20, 2023, 1:18 PM EDT) -- WASHINGTON, D.C. — Because a rule grants states and insurers flexibility in determining whether manufacturers’ drug assistance programs fall under the cost-sharing requirements of the Patient Protection and Affordable Care Act (ACA) and doesn’t determine substantive rights, a legal challenge to it fails, the government tells a federal judge in a cross-motion for summary judgment and opposition....